These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38279474)
41. [Change of T lymphocyte and its activated subsets in SARS patients]. Yu XY; Zhang YC; Han CW; Wang P; Xue XJ; Cong YL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):542-6. PubMed ID: 14650154 [TBL] [Abstract][Full Text] [Related]
42. Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome. Bobcakova A; Petriskova J; Vysehradsky R; Kocan I; Kapustova L; Barnova M; Diamant Z; Jesenak M Front Cell Infect Microbiol; 2021; 11():646688. PubMed ID: 33937096 [TBL] [Abstract][Full Text] [Related]
43. Comparison of T Lymphocyte Subsets and Natural Killer Lymphocytes in Moderate Versus Severe COVID-19 Patients. Gabr H; Abdel Aal AA; Bastawy S; Fateen M; Abd El Dayem OY; Youssef EA; Afifi R; Kamal M Viral Immunol; 2023 May; 36(4):250-258. PubMed ID: 36847755 [TBL] [Abstract][Full Text] [Related]
44. Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity. Dai W; Zhong A; Qiao Q; Wu J; Li W; Wu Q; Zhou H; Qin S; Jiang W; Zhang J; Xia X Virol J; 2022 Nov; 19(1):192. PubMed ID: 36403042 [TBL] [Abstract][Full Text] [Related]
45. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885 [TBL] [Abstract][Full Text] [Related]
46. Peripheral blood lymphocyte subsets in patients with stomach cancer. Hong WS; Min YI; Son YS; Hong SI J Korean Med Sci; 1995 Jun; 10(3):164-8. PubMed ID: 8527041 [TBL] [Abstract][Full Text] [Related]
47. T-lymphocyte subsets in West African children: impact of age, sex, and season. Lisse IM; Aaby P; Whittle H; Jensen H; Engelmann M; Christensen LB J Pediatr; 1997 Jan; 130(1):77-85. PubMed ID: 9003854 [TBL] [Abstract][Full Text] [Related]
48. Decreased T cell populations contribute to the increased severity of COVID-19. Liu R; Wang Y; Li J; Han H; Xia Z; Liu F; Wu K; Yang L; Liu X; Zhu C Clin Chim Acta; 2020 Sep; 508():110-114. PubMed ID: 32405080 [TBL] [Abstract][Full Text] [Related]
49. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics. Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458 [TBL] [Abstract][Full Text] [Related]
50. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4 Mahmoudi S; Yaghmaei B; Sharifzadeh Ekbatani M; Pourakbari B; Navaeian A; Parvaneh N; Haghi Ashtiani MT; Mamishi S Front Pediatr; 2021; 9():643299. PubMed ID: 33937149 [No Abstract] [Full Text] [Related]
51. The clinical course and its correlated immune status in COVID-19 pneumonia. He R; Lu Z; Zhang L; Fan T; Xiong R; Shen X; Feng H; Meng H; Lin W; Jiang W; Geng Q J Clin Virol; 2020 Jun; 127():104361. PubMed ID: 32344320 [TBL] [Abstract][Full Text] [Related]
52. Elevated Exhaustion Levels of NK and CD8 Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D Front Immunol; 2020; 11():580237. PubMed ID: 33154753 [TBL] [Abstract][Full Text] [Related]
53. Characteristics and Predictive Value of T-lymphocyte Subset Absolute Counts in Patients with COVID-19-associated Acute Respiratory Failure: A Retrospective Study. Vadi S; Pednekar A; Suthar D; Sanwalka N; Ghodke K; Rabade N Indian J Crit Care Med; 2022 Nov; 26(11):1198-1203. PubMed ID: 36873590 [TBL] [Abstract][Full Text] [Related]
54. The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients. Kandeel EZ; Refaat L; Bayoumi A; Nooh HA; Hammad R; Khafagy M; Abdellateif MS Viral Immunol; 2022 Sep; 35(7):491-502. PubMed ID: 35930238 [TBL] [Abstract][Full Text] [Related]
55. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091 [TBL] [Abstract][Full Text] [Related]
56. Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir. Sun Y; Dian Y; Gao Q; Deng G Front Immunol; 2023; 14():1227905. PubMed ID: 37799722 [TBL] [Abstract][Full Text] [Related]
57. [Study of hypoxia-induced immune injury and its intervention measure]. Tian YM; Nie HJ; Liu JY; Zan JP; Zhang YK; Zhang DX; Wang H Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Nov; 26(4):404-10. PubMed ID: 21328972 [TBL] [Abstract][Full Text] [Related]
58. Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients. Idiz UO; Yurttas TT; Degirmencioglu S; Orhan B; Erdogan E; Sevik H; Sevinc MM J Med Virol; 2022 Oct; 94(10):4744-4753. PubMed ID: 35667877 [TBL] [Abstract][Full Text] [Related]
60. Clinical significance of cellular immunity function and inflammatory factors assays in alveolar lavage fluid for severe COVID-19 pneumonia. Liao L; Yang GH J Med Virol; 2021 May; 93(5):2979-2987. PubMed ID: 33506950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]